0.6000GBp+9.09%Mkt Cap: 2.67M GBpP/E: —Last update: 2026-05-13
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Swit…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-0.02
PEG—
P/B5.75
P/S2.58
EV/EBITDA-2.84
EV/Revenue1.47
EPS (TTM)0.00
EPS (Forward)-0.34
Cash Flow & Leverage
FCF Yield-11.86%
FCF Margin-31.45%
Operating CF-546.14K GBp
CapEx (TTM)3.94K GBp
Net Debt/EBITDA0.49
Net Debt-257.00K GBp
Technical
SMA 500.4877 (+23.0%)
SMA 2000.4267 (+40.6%)
Beta0.95
S&P 52W Chg24.23%
Avg Vol (30d)5.13M
Avg Vol (10d)8.77M
Technical Indicators
RSI (14)70.4
MACD0.0186
MACD Signal0.0113
MACD Hist.+0.0072
BB Upper0.5648 GBp
BB Middle0.5030 GBp
BB Lower0.4412 GBp
BB Width24.59%
ATR (14)0.0680 GBp
Vol Ratio (20d)0.45x
52W Range
0.253064% of range0.7990
52W High0.7990 GBp
52W Low0.2530 GBp
Profitability
Gross Margin-50.89%
EBITDA Margin-51.91%
Profit Margin-52.97%
Oper. Margin-61.93%
ROE-59.99%
ROA-46.55%
Revenue Growth49.20%
Earnings Growth—
Balance Sheet
Debt/Equity—
Current Ratio3.30
Quick Ratio3.30
Book Value/Sh0.0010 GBp
Cash/Share0.0010 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateDec 19, 2016
Ownership
Shares Out.453.21M
Float218.09M
Insiders22.73%
Institutions1.20%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap2.67M GBp
Enterprise Value1.49M GBp
Revenue (TTM)1.01M GBp
Gross Profit-513.08K GBp
Net Income (TTM)-415.25K GBp
Revenue/Share0.0030 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees10
Last Price0.6000 GBp
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—